Dako sails with Swedish ownership

Denmark-based Dako, parent company of the division formerly known as Cytomation, recently joined the list of Northern Colorado employers that will operate under private-equity ownership.

In late February, private equity firm EQT of Stockholm, Sweden moved to purchase the cancer-diagnostics company for 7.25 billion kroner, or about $1.29 billion. The deal is expected to close in April or May.

The Dako buyout is not expected to affect the 250 employees at the Fort Collins site, nor is it likely to sway Dako from its previously charted course.

“There are no plans for any closures or corporate restructuring,´ said Cindy Coughenour, general manager of…